{
  "trial_id": "NCT00147199",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Race, Body Mass Index (BMI), Baseline 6-minute walk distance, New York Heart Association (NYHA) Class, Type of PAH (idiopathic, familial, collagen vascular disease associated, HIV, anorexigen-induced), Duration of PAH diagnosis, Baseline pulmonary artery pressure (PAPm), Baseline pulmonary capillary wedge pressure (PCWP), Baseline pulmonary vascular resistance (PVR), Concomitant PAH medications (bosentan, sildenafil), Smoking status, History of cardiovascular disease, History of musculoskeletal disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Pulmonary Arterial Hypertension (PAH) Etiology",
          "Type of PAH (idiopathic, familial, collagen vascular disease associated, HIV, anorexigen-induced)"
        ],
        [
          "Background PAH Therapy",
          "Concomitant PAH medications (bosentan, sildenafil)"
        ],
        [
          "Baseline NYHA Class",
          "New York Heart Association (NYHA) Class"
        ],
        [
          "Baseline Six-Minute Walk Distance (6MWD)",
          "Baseline 6-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Time on Background Therapy"
      ],
      "remaining_candidate_features": [
        "Race",
        "Body Mass Index (BMI)",
        "Duration of PAH diagnosis",
        "Baseline pulmonary artery pressure (PAPm)",
        "Baseline pulmonary capillary wedge pressure (PCWP)",
        "Baseline pulmonary vascular resistance (PVR)",
        "Smoking status",
        "History of cardiovascular disease",
        "History of musculoskeletal disease"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, NYHA Class, Baseline 6-minute walk distance, Pulmonary artery pressure, Pulmonary capillary wedge pressure, Pulmonary vascular resistance, Type of PAH, Duration of PAH, Concomitant PAH medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Pulmonary Arterial Hypertension (PAH) Etiology",
          "Type of PAH"
        ],
        [
          "Background PAH Therapy",
          "Concomitant PAH medications"
        ],
        [
          "Baseline NYHA Class",
          "NYHA Class"
        ],
        [
          "Baseline Six-Minute Walk Distance (6MWD)",
          "Baseline 6-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Time on Background Therapy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Pulmonary artery pressure",
        "Pulmonary capillary wedge pressure",
        "Pulmonary vascular resistance",
        "Duration of PAH"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, New York Heart Association (NYHA) Class, Six-minute walk distance, Mean pulmonary artery pressure, Pulmonary capillary wedge pressure, Pulmonary vascular resistance, Bosentan dose, Sildenafil dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline NYHA Class",
          "New York Heart Association (NYHA) Class"
        ],
        [
          "Baseline Six-Minute Walk Distance (6MWD)",
          "Six-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Pulmonary Arterial Hypertension (PAH) Etiology",
        "Background PAH Therapy",
        "Time on Background Therapy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Mean pulmonary artery pressure",
        "Pulmonary capillary wedge pressure",
        "Pulmonary vascular resistance",
        "Bosentan dose",
        "Sildenafil dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), New York Heart Association (NYHA) Class, duration of PAH, etiology of PAH (idiopathic, familial, collagen vascular disease associated, HIV associated, anorexigen associated), bosentan dose, sildenafil dose, 6-minute walk distance at screening, mean pulmonary artery pressure (PAPm), pulmonary capillary wedge pressure (PCWP), pulmonary vascular resistance (PVR).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Pulmonary Arterial Hypertension (PAH) Etiology",
          "etiology of PAH (idiopathic, familial, collagen vascular disease associated, HIV associated, anorexigen associated)"
        ],
        [
          "Background PAH Therapy",
          "bosentan dose"
        ],
        [
          "Time on Background Therapy",
          "duration of PAH"
        ],
        [
          "Baseline NYHA Class",
          "New York Heart Association (NYHA) Class"
        ],
        [
          "Baseline Six-Minute Walk Distance (6MWD)",
          "6-minute walk distance at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "sildenafil dose",
        "mean pulmonary artery pressure (PAPm)",
        "pulmonary capillary wedge pressure (PCWP)",
        "pulmonary vascular resistance (PVR)."
      ]
    }
  }
}